Preparation and evaluation of clinical effects of glucantime gel mask

Journal of Isfahan Medical School

Volumn 31, Issue 231, 2013, Pages

  Mostafavi, Sayed Abolfazl ^a   Shatalebi, Mohammad Ali ^a   Attar, Ahmad Movahedian ^a   Hejazi, Hossein ^b   Mottaghinejad, Amin ^a   Fadaei, Reza ^a   Ramezanpour, Javad ^a   Zarrinzamir, Parastoo ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Gel mask; Leishmaniasis; Meglumine antimoniate

Indexed keywords

CARBOXYMETHYLCELLULOSE; GLUCANTIME GEL MASK; GLYCEROL; HYDROXYPROPYLMETHYLCELLULOSE; MEGLUMINE ANTIMONATE; PLACEBO; POLYVINYL ALCOHOL; TOPICAL AGENT; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG DOSAGE FORM; DRUG MANUFACTURE; DRUG PENETRATION; DRUG RELEASE; FEMALE; HUMAN; MALE; PHYSICAL CHEMISTRY; RANDOMIZED CONTROLLED TRIAL; SKIN LEISHMANIASIS; TOPICAL TREATMENT; TREATMENT OUTCOME;

EID: 84940300937     PISSN: 10277595     EISSN: 1735854X     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Ershadi MR, Zahraei-Ramazani AR, Akhavan AA, Jalali-Zand AR, Abdoli H, Nadim A. Rodent control operations against zoonotic cutaneous leishmaniasis in rural Iran. Ann Saudi Med 2005; 25(4): 309-12.
2. Bailey MS, Lockwood DN. Cutaneous leishmaniasis. Clin Dermatol 2007; 25(2): 203-11.
3. Nilforoushzadeh M, Sadeghian G. Cutaneous leishmaniosis. 1st ed. Isfahan, Iran: Isfahan University of Medical Sciences; 2002. [In Persian].
4. Lewis DJ. The biology of Phlebotomidae in relation to leishmaniasis. Annu Rev Entomol 1974; 19: 363-84.
5. Gonzalez U, Pinart M, Reveiz L, Alvar J. Interventions for Old World cutaneous leishmaniasis. Cochrane Database Syst Rev 2008; (4): CD005067.
6. Kim DH, Chung HJ, Bleys J, Ghohestani RF. Is paromomycin an effective and safe treatment against cutaneous leishmaniasis? A metaanalysis of 14 randomized controlled trials. PLoS Negl Trop Dis 2009; 3(2): e381.
7. Larbi EB, al-Khawajah A, al-Gindan Y, Jain S, Abahusain A, al-Zayer A. A randomized, double-blind, clinical trial of topical clotrimazole versus miconazole for treatment of cutaneous leishmaniasis in the eastern province of Saudi Arabia. Am J Trop Med Hyg 1995; 52(2): 166-8.
8. Davidson RN, Yardley V, Croft SL, Konecny P, Benjamin N. A topical nitric oxide-generating therapy for cutaneous leishmaniasis. Trans R Soc Trop Med Hyg 2000; 94(3): 319-22.
9. Zeina B, Banfield C, al-Assad S. Topical glyceryl trinitrate: a possible treatment for cutaneous leishmaniasis. Clin Exp Dermatol 1997; 22(5): 244-5.
10. Punitha S, Girish Y. Polymers in muco adhesive buccal drug delivery system-Areview. Int J Res Pharm Sci 2010; 1(2): 170-86.
11. Salamat-Miller N, Chittchang M, Johnston TP. The use of mucoadhesive polymers in buccal drug delivery. Adv Drug Deliv Rev 2005; 57(11): 1666-91.
12. Asilian A, Jalayer T, Whitworth JA, Ghasemi RL, Nilforooshzadeh M, Olliaro P. A randomized, placebo-controlled trial of a two week regimen of aminosidine (paromomycin) ointment for treatment of cutaneous leishmaniasis in Iran. Am J Trop Med Hyg 1995; 53(6): 648-51.
13. Asilian A, Davami M. Comparison between the efficacy of photodynamic therapy and topical paromomycin in the treatment of Old World cutaneous leishmaniasis: a placebo-controlled, randomized clinical trial. Clin Exp Dermatol 2006; 31(5): 634-7.
14. Clive S, Leonard RC. Miltefosine in recurrent cutaneous breast cancer. Lancet 1997; 349(9052): 621-2.
15. Schmidt-Ott R, Klenner T, Overath P, Aebischer T. Topical treatment with hexadecylphosphocholine (Miltex) efficiently reduces parasite burden in experimental cutaneous leishmaniasis. Trans R Soc Trop Med Hyg 1999; 93(1): 85-90.
16. Buates S, Matlashewski G. Treatment of experimental leishmaniasis with the immunomodulators imiquimod and S-28463: efficacy and mode of action. J Infect Dis 1999; 179(6): 1485-94.
17. Ilg T, Fuchs M, Gnau V, Wolfram M, Harbecke D, Overath P. Distribution of parasite cysteine proteinases in lesions of mice infected with Leishmania mexicana amastigotes. Mol Biochem Parasitol 1994; 67(2): 193-203.
18. El-On J, Jacobs GP, Witztum E, Greenblatt CL. Development of topical treatment for cutaneous leishmaniasis caused by Leishmania major in experimental animals. Antimicrob Agents Chemother 1984; 26(5): 745-51.